Label: GLYCERIN suppository
- NDC Code(s): 37808-399-25
- Packager: H E B
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Updated November 3, 2021
If you are a consumer or patient please visit this version.
- Active ingredient (in each suppository)
For rectal use only
May cause rectal discomfort or a burning sensation.
Ask a doctor before using any laxative if child has
- abdominal pain, nausea or vomiting
- a sudden change in bowel habits lasting more than 2 weeks
- already used a laxative formore than 1 week
Stop use and consult a doctor if child has
- rectal bleeding
- no bowel movement within 1 hour using this product
These symptoms may indicate a serious condition.
- Directions - single daily dose
- Other information
- Inactive ingredients
- Questions or comments?
INGREDIENTS AND APPEARANCE
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:37808-399 Route of Administration RECTAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN 1 g Inactive Ingredients Ingredient Name Strength SODIUM HYDROXIDE (UNII: 55X04QC32I) STEARIC ACID (UNII: 4ELV7Z65AP) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:37808-399-25 25 in 1 JAR; Type 0: Not a Combination Product 09/23/2016 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part334 09/23/2016 Labeler - H E B (007924756) Registrant - DSC Laboratories, Inc. (097807374) Establishment Name Address ID/FEI Business Operations DSC Laboratories, Inc. 097807374 manufacture(37808-399)